Nurix Therapeutics, Inc. (NRIX) · Insider trading

What Nurix Therapeutics's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.

Bought, 12 months

0 insiders, 0 trades

Sold, 12 months

$5.23M

4 insiders, 76% under a plan

Net, 12 months

−$5.23M

bought less sold

Latest filing

2026-10-15

filings read to 2026-10-19

Bought and sold at the market, by month

Two years. Purchases above the line, sales below, in dollars.

Bought Sold Largest month: $823,573

Who traded, two years

Insider	Bought	Sold	Trades	Last trade	Holds after
Ring ChristineChief Legal Officer	–	$4.22M	32	2026-10-02	9,110
van Houte HansChief Financial Officer	–	$1.13M	20	2026-08-04	43,133
Hansen GwennChief Scientific Officer	–	$914,609	16	2026-10-15	117,227
Gregory Julia PDirector	–	$528,528	1	2026-10-14	10,750

Open-market purchases and sales

Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.

Date	Insider	Trade	Shares	Price	Value	Holds after	Filing
2026-10-15	Hansen GwennChief Scientific Officer	Saleplan	1,452	25.00	$36,300	117,227	Form 4
2026-10-14	Gregory Julia PDirector	Sale	22,583	23.40	$528,528	10,750	Form 4
2026-10-02	Ring ChristineChief Legal Officer	Saleplan	5,786	23.19	$134,149	9,110	Form 4
2026-09-02	Ring ChristineChief Legal Officer	Saleplan	5,387	25.69	$138,392	9,510	Form 4
2026-09-02	Ring ChristineChief Legal Officer	Saleplan	400	26.64	$10,656	9,110	Form 4
2026-09-01	Hansen GwennChief Scientific Officer	Saleplan	1,452	25.47	$36,982	117,227	Form 4
2026-08-05	Hansen GwennChief Scientific Officer	Saleplan	4,356	25.00	$108,900	117,227	Form 4
2026-08-04	Hansen GwennChief Scientific Officer	Saleplan	1,500	23.87	$35,805	119,838	Form 4
2026-08-04	Hansen GwennChief Scientific Officer	Saleplan	2,611	24.64	$64,335	117,227	Form 4
2026-08-04	van Houte HansChief Financial Officer	Saleplan	1,794	23.89	$42,859	43,133	Form 4
2026-08-04	van Houte HansChief Financial Officer	Saleplan	2,967	24.65	$73,137	40,166	Form 4
2026-08-03	Ring ChristineChief Legal Officer	Saleplan	16,589	23.05	$382,376	9,110	Form 4
2026-07-30	Hansen GwennChief Scientific Officer	Sale	3,847	23.38	$89,943	121,338	Form 4
2026-07-30	Ring ChristineChief Legal Officer	Sale	3,847	23.38	$89,943	19,912	Form 4
2026-07-30	van Houte HansChief Financial Officer	Sale	2,845	23.38	$66,516	44,927	Form 4
2026-07-02	Ring ChristineChief Legal Officer	Saleplan	11,008	23.56	$259,348	13,579	Form 4
2026-06-25	Hansen GwennChief Scientific Officer	Saleplan	5,394	20.00	$107,880	115,005	Form 4
2026-06-25	Ring ChristineChief Legal Officer	Saleplan	28,935	20.06	$580,436	13,579	Form 4
2026-06-02	Ring ChristineChief Legal Officer	Saleplan	8,148	16.60	$135,257	13,579	Form 4
2026-05-05	van Houte HansChief Financial Officer	Saleplan	13,473	16.58	$223,382	38,174	Form 4
2026-05-05	van Houte HansChief Financial Officer	Saleplan	582	17.18	$9,999	37,592	Form 4
2026-05-04	Ring ChristineChief Legal Officer	Saleplan	8,148	16.96	$138,190	18,305	Form 4
2026-05-01	Ring ChristineChief Legal Officer	Saleplan	5,394	16.76	$90,403	26,453	Form 4
2026-04-30	Hansen GwennChief Scientific Officer	Sale	3,214	16.65	$53,513	120,399	Form 4
2026-04-30	Ring ChristineChief Legal Officer	Sale	3,214	16.65	$53,513	31,847	Form 4
2026-04-30	van Houte HansChief Financial Officer	Sale	2,388	16.65	$39,760	51,647	Form 4
2026-04-02	Ring ChristineChief Legal Officer	Saleplan	8,148	15.24	$124,176	26,453	Form 4
2026-03-02	Ring ChristineChief Legal Officer	Saleplan	8,148	15.44	$125,805	34,601	Form 4
2026-02-09	Ring ChristineChief Legal Officer	Saleplan	14,261	16.66	$237,588	42,749	Form 4
2026-01-30	Hansen GwennChief Scientific Officer	Sale	4,797	16.58	$79,534	83,770	Form 4
2026-01-30	Hansen GwennChief Scientific Officer	Sale	98	17.37	$1,702	83,672	Form 4
2026-01-30	Ring ChristineChief Legal Officer	Sale	4,333	16.58	$71,841	57,098	Form 4
2026-01-30	Ring ChristineChief Legal Officer	Sale	88	17.37	$1,529	57,010	Form 4
2026-01-30	van Houte HansChief Financial Officer	Sale	3,588	16.58	$59,489	45,500	Form 4
2026-01-30	van Houte HansChief Financial Officer	Sale	73	17.37	$1,268	45,427	Form 4
2026-01-20	Ring ChristineChief Legal Officer	Saleplan	3,760	18.42	$69,259	50,897	Form 4
2025-12-18	Ring ChristineChief Legal Officer	Saleplan	3,560	17.87	$63,617	51,097	Form 4
2025-12-18	Ring ChristineChief Legal Officer	Saleplan	200	18.56	$3,712	50,897	Form 4
2025-11-24	Ring ChristineChief Legal Officer	Saleplan	37,600	17.07	$641,832	50,897	Form 4
2025-11-03	van Houte HansChief Financial Officer	Saleplan	6,284	12.56	$78,927	37,592	Form 4

29 more

2025-10-30	Hansen GwennChief Scientific Officer	Sale	4,087	12.80	$52,314	76,751	Form 4
2025-10-30	Ring ChristineChief Legal Officer	Sale	3,644	12.80	$46,643	50,897	Form 4
2025-10-30	van Houte HansChief Financial Officer	Sale	3,130	12.80	$40,064	43,876	Form 4
2025-08-01	van Houte HansChief Financial Officer	Saleplan	5,402	11.03	$59,584	35,512	Form 4
2025-07-30	Hansen GwennChief Scientific Officer	Sale	4,308	12.01	$51,739	69,023	Form 4
2025-07-30	Ring ChristineChief Legal Officer	Sale	3,841	12.01	$46,130	44,009	Form 4
2025-07-30	van Houte HansChief Financial Officer	Sale	4,304	12.01	$51,691	40,914	Form 4
2025-05-02	van Houte HansChief Financial Officer	Saleplan	6,198	11.33	$70,223	33,724	Form 4
2025-04-30	van Houte HansChief Financial Officer	Sale	2,438	11.50	$28,037	39,922	Form 4
2025-04-30	Ring ChristineChief Legal Officer	Sale	2,894	11.50	$33,281	37,318	Form 4
2025-04-30	Hansen GwennChief Scientific Officer	Sale	3,377	11.50	$38,836	61,516	Form 4
2025-03-03	van Houte HansChief Financial Officer	Saleplan	5,125	14.40	$73,800	34,424	Form 4
2025-03-03	van Houte HansChief Financial Officer	Saleplan	700	15.13	$10,591	33,724	Form 4
2025-01-31	Ring ChristineChief Legal Officer	Saleplan	5,660	19.94	$112,860	32,638	Form 4
2025-01-31	Ring ChristineChief Legal Officer	Saleplan	100	20.48	$2,048	32,538	Form 4
2025-01-30	van Houte HansChief Financial Officer	Sale	2,557	19.81	$50,654	39,803	Form 4
2025-01-30	van Houte HansChief Financial Officer	Sale	254	20.33	$5,164	39,549	Form 4
2025-01-30	Hansen GwennChief Scientific Officer	Sale	3,357	19.81	$66,502	56,270	Form 4
2025-01-30	Hansen GwennChief Scientific Officer	Sale	333	20.33	$6,770	55,937	Form 4
2025-01-30	Ring ChristineChief Legal Officer	Sale	2,929	19.81	$58,023	32,829	Form 4
2025-01-30	Ring ChristineChief Legal Officer	Sale	291	20.33	$5,916	32,538	Form 4
2025-01-02	Ring ChristineChief Legal Officer	Saleplan	5,760	19.50	$112,320	28,084	Form 4
2024-12-02	Ring ChristineChief Legal Officer	Saleplan	5,760	21.73	$125,165	28,084	Form 4
2024-11-04	Ring ChristineChief Legal Officer	Saleplan	3,290	25.00	$82,250	28,084	Form 4
2024-11-01	van Houte HansChief Financial Officer	Saleplan	3,546	24.28	$86,097	33,724	Form 4
2024-11-01	Ring ChristineChief Legal Officer	Saleplan	5,760	24.28	$139,853	28,084	Form 4
2024-10-30	Ring ChristineChief Legal Officer	Sale	4,182	24.31	$101,664	28,084	Form 4
2024-10-30	Hansen GwennChief Scientific Officer	Sale	3,437	24.31	$83,553	50,670	Form 4
2024-10-30	van Houte HansChief Financial Officer	Sale	2,368	24.31	$57,566	37,270	Form 4

Grants, exercises and other transactions

Pay, tax and paperwork rather than a choice to trade at the market price. Two years.

104 × option exercise

Show them

Date	Insider	What	Shares	Price	Holds after	Filing
2026-10-15	Hansen GwennChief Scientific Officer	Option exercise M	+1,452	1.86	118,679	Form 4
2026-10-14	Gregory Julia PDirector	Option exercise M	+22,583	1.86	33,333	Form 4
2026-10-02	Ring ChristineChief Legal Officer	Option exercise M	+5,786	8.72	14,896	Form 4
2026-09-02	Ring ChristineChief Legal Officer	Option exercise M	+5,787	8.72	14,897	Form 4
2026-09-01	Hansen GwennChief Scientific Officer	Option exercise M	+1,452	1.86	118,679	Form 4
2026-08-05	Hansen GwennChief Scientific Officer	Option exercise M	+4,356	1.86	121,583	Form 4
2026-08-03	Ring ChristineChief Legal Officer	Option exercise M	+5,787	8.72	25,699	Form 4
2026-07-30	Hansen GwennChief Scientific Officer	Option exercise M	+3,750	–	118,755	Form 4
2026-07-30	Hansen GwennChief Scientific Officer	Option exercise M	+2,858	–	121,613	Form 4
2026-07-30	Hansen GwennChief Scientific Officer	Option exercise M	+3,572	–	125,185	Form 4
2026-07-30	Ring ChristineChief Legal Officer	Option exercise M	+3,750	–	17,329	Form 4
2026-07-30	Ring ChristineChief Legal Officer	Option exercise M	+2,858	–	20,187	Form 4
2026-07-30	Ring ChristineChief Legal Officer	Option exercise M	+3,572	–	23,759	Form 4
2026-07-30	van Houte HansChief Financial Officer	Option exercise M	+3,750	–	41,342	Form 4
2026-07-30	van Houte HansChief Financial Officer	Option exercise M	+2,858	–	44,200	Form 4
2026-07-30	van Houte HansChief Financial Officer	Option exercise M	+3,572	–	47,772	Form 4
2026-07-02	Ring ChristineChief Legal Officer	Option exercise M	+5,221	1.86	18,800	Form 4
2026-07-02	Ring ChristineChief Legal Officer	Option exercise M	+5,787	8.72	24,587	Form 4
2026-06-25	Ring ChristineChief Legal Officer	Option exercise M	+13,333	7.26	26,912	Form 4
2026-06-25	Ring ChristineChief Legal Officer	Option exercise M	+15,602	8.72	42,514	Form 4
2026-06-02	Ring ChristineChief Legal Officer	Option exercise M	+3,422	1.86	21,727	Form 4
2026-04-30	Hansen GwennChief Scientific Officer	Option exercise M	+2,000	–	117,005	Form 4
2026-04-30	Hansen GwennChief Scientific Officer	Option exercise M	+3,750	–	120,755	Form 4
2026-04-30	Hansen GwennChief Scientific Officer	Option exercise M	+2,858	–	123,613	Form 4
2026-04-30	Ring ChristineChief Legal Officer	Option exercise M	+2,000	–	28,453	Form 4
2026-04-30	Ring ChristineChief Legal Officer	Option exercise M	+3,750	–	32,203	Form 4
2026-04-30	Ring ChristineChief Legal Officer	Option exercise M	+2,858	–	35,061	Form 4
2026-04-30	van Houte HansChief Financial Officer	Option exercise M	+2,000	–	47,427	Form 4
2026-04-30	van Houte HansChief Financial Officer	Option exercise M	+3,750	–	51,177	Form 4
2026-04-30	van Houte HansChief Financial Officer	Option exercise M	+2,858	–	54,035	Form 4
2026-02-03	Hansen GwennChief Scientific Officer	Option exercise M	+31,333	0.84	115,005	Form 4
2026-01-30	Hansen GwennChief Scientific Officer	Option exercise M	+3,207	–	79,958	Form 4
2026-01-30	Hansen GwennChief Scientific Officer	Option exercise M	+2,000	–	81,958	Form 4
2026-01-30	Hansen GwennChief Scientific Officer	Option exercise M	+3,750	–	85,708	Form 4
2026-01-30	Hansen GwennChief Scientific Officer	Option exercise M	+2,859	–	88,567	Form 4
2026-01-30	Ring ChristineChief Legal Officer	Option exercise M	+1,925	–	52,822	Form 4
2026-01-30	Ring ChristineChief Legal Officer	Option exercise M	+2,000	–	54,822	Form 4
2026-01-30	Ring ChristineChief Legal Officer	Option exercise M	+3,750	–	58,572	Form 4
2026-01-30	Ring ChristineChief Legal Officer	Option exercise M	+2,859	–	61,431	Form 4
2026-01-30	van Houte HansChief Financial Officer	Option exercise M	+2,887	–	40,479	Form 4
2026-01-30	van Houte HansChief Financial Officer	Option exercise M	+2,000	–	42,479	Form 4
2026-01-30	van Houte HansChief Financial Officer	Option exercise M	+3,750	–	46,229	Form 4
2026-01-30	van Houte HansChief Financial Officer	Option exercise M	+2,859	–	49,088	Form 4
2026-01-20	Ring ChristineChief Legal Officer	Option exercise M	+3,760	1.86	54,657	Form 4
2025-12-18	Ring ChristineChief Legal Officer	Option exercise M	+3,760	1.86	54,657	Form 4
2025-11-24	Ring ChristineChief Legal Officer	Option exercise M	+37,600	1.86	88,497	Form 4
2025-10-30	Hansen GwennChief Scientific Officer	Option exercise M	+3,207	–	72,230	Form 4
2025-10-30	Hansen GwennChief Scientific Officer	Option exercise M	+2,000	–	74,230	Form 4
2025-10-30	Hansen GwennChief Scientific Officer	Option exercise M	+3,750	–	77,980	Form 4
2025-10-30	Hansen GwennChief Scientific Officer	Option exercise M	+2,858	–	80,838	Form 4
2025-10-30	Ring ChristineChief Legal Officer	Option exercise M	+1,924	–	45,933	Form 4
2025-10-30	Ring ChristineChief Legal Officer	Option exercise M	+2,000	–	47,933	Form 4
2025-10-30	Ring ChristineChief Legal Officer	Option exercise M	+3,750	–	51,683	Form 4
2025-10-30	Ring ChristineChief Legal Officer	Option exercise M	+2,858	–	54,541	Form 4
2025-10-30	van Houte HansChief Financial Officer	Option exercise M	+2,886	–	38,398	Form 4
2025-10-30	van Houte HansChief Financial Officer	Option exercise M	+2,000	–	40,398	Form 4
2025-10-30	van Houte HansChief Financial Officer	Option exercise M	+3,750	–	44,148	Form 4
2025-10-30	van Houte HansChief Financial Officer	Option exercise M	+2,858	–	47,006	Form 4
2025-09-17	Gregory Julia PDirector	Option exercise M	+10,750	1.86	10,750	Form 4
2025-07-30	Hansen GwennChief Scientific Officer	Option exercise M	+3,207	–	64,723	Form 4
2025-07-30	Hansen GwennChief Scientific Officer	Option exercise M	+2,000	–	66,723	Form 4
2025-07-30	Hansen GwennChief Scientific Officer	Option exercise M	+3,750	–	70,473	Form 4
2025-07-30	Hansen GwennChief Scientific Officer	Option exercise M	+2,858	–	73,331	Form 4
2025-07-30	Ring ChristineChief Legal Officer	Option exercise M	+1,924	–	39,242	Form 4
2025-07-30	Ring ChristineChief Legal Officer	Option exercise M	+2,000	–	41,242	Form 4
2025-07-30	Ring ChristineChief Legal Officer	Option exercise M	+3,750	–	44,992	Form 4
2025-07-30	Ring ChristineChief Legal Officer	Option exercise M	+2,858	–	47,850	Form 4
2025-07-30	van Houte HansChief Financial Officer	Option exercise M	+2,886	–	36,610	Form 4
2025-07-30	van Houte HansChief Financial Officer	Option exercise M	+2,000	–	38,610	Form 4
2025-07-30	van Houte HansChief Financial Officer	Option exercise M	+3,750	–	42,360	Form 4
2025-07-30	van Houte HansChief Financial Officer	Option exercise M	+2,858	–	45,218	Form 4
2025-04-30	van Houte HansChief Financial Officer	Option exercise M	+2,886	–	36,610	Form 4
2025-04-30	van Houte HansChief Financial Officer	Option exercise M	+2,000	–	38,610	Form 4
2025-04-30	van Houte HansChief Financial Officer	Option exercise M	+3,750	–	42,360	Form 4
2025-04-30	Ring ChristineChief Legal Officer	Option exercise M	+1,924	–	34,462	Form 4
2025-04-30	Ring ChristineChief Legal Officer	Option exercise M	+2,000	–	36,462	Form 4
2025-04-30	Ring ChristineChief Legal Officer	Option exercise M	+3,750	–	40,212	Form 4
2025-04-30	Hansen GwennChief Scientific Officer	Option exercise M	+3,206	–	59,143	Form 4
2025-04-30	Hansen GwennChief Scientific Officer	Option exercise M	+2,000	–	61,143	Form 4
2025-04-30	Hansen GwennChief Scientific Officer	Option exercise M	+3,750	–	64,893	Form 4
2025-01-31	Ring ChristineChief Legal Officer	Option exercise M	+223	1.86	32,761	Form 4
2025-01-31	Ring ChristineChief Legal Officer	Option exercise M	+5,537	1.86	38,298	Form 4
2025-01-30	van Houte HansChief Financial Officer	Option exercise M	+2,886	–	36,610	Form 4
2025-01-30	van Houte HansChief Financial Officer	Option exercise M	+2,000	–	38,610	Form 4
2025-01-30	van Houte HansChief Financial Officer	Option exercise M	+3,750	–	42,360	Form 4
2025-01-30	Hansen GwennChief Scientific Officer	Option exercise M	+3,207	–	53,877	Form 4
2025-01-30	Hansen GwennChief Scientific Officer	Option exercise M	+2,000	–	55,877	Form 4
2025-01-30	Hansen GwennChief Scientific Officer	Option exercise M	+3,750	–	59,627	Form 4
2025-01-30	Ring ChristineChief Legal Officer	Option exercise M	+1,924	–	30,008	Form 4
2025-01-30	Ring ChristineChief Legal Officer	Option exercise M	+2,000	–	32,008	Form 4
2025-01-30	Ring ChristineChief Legal Officer	Option exercise M	+3,750	–	35,758	Form 4
2025-01-02	Ring ChristineChief Legal Officer	Option exercise M	+5,760	1.86	33,844	Form 4
2024-12-02	Ring ChristineChief Legal Officer	Option exercise M	+5,760	1.86	33,844	Form 4
2024-11-04	Ring ChristineChief Legal Officer	Option exercise M	+3,290	9.57	31,374	Form 4
2024-11-01	Ring ChristineChief Legal Officer	Option exercise M	+5,760	1.86	33,844	Form 4
2024-10-30	Ring ChristineChief Legal Officer	Option exercise M	+1,924	–	26,516	Form 4
2024-10-30	Ring ChristineChief Legal Officer	Option exercise M	+2,000	–	28,516	Form 4
2024-10-30	Ring ChristineChief Legal Officer	Option exercise M	+3,750	–	32,266	Form 4
2024-10-30	Hansen GwennChief Scientific Officer	Option exercise M	+3,207	–	48,357	Form 4
2024-10-30	Hansen GwennChief Scientific Officer	Option exercise M	+2,000	–	50,357	Form 4
2024-10-30	Hansen GwennChief Scientific Officer	Option exercise M	+3,750	–	54,107	Form 4
2024-10-30	van Houte HansChief Financial Officer	Option exercise M	+2,886	–	33,888	Form 4
2024-10-30	van Houte HansChief Financial Officer	Option exercise M	+2,000	–	35,888	Form 4
2024-10-30	van Houte HansChief Financial Officer	Option exercise M	+3,750	–	39,638	Form 4

How to read it

Buy, sale: Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
Plan: A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
Holds after: The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
Value: Shares times the price the form reports, which is often an average over several fills on the day.

Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.

Nurix Therapeutics's scores and multiples ›